Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Breast Cancer

  Free Subscription


Articles published in Nat Rev Clin Oncol

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    December 2019
  1. GOUTSOULIAK K, Veeraraghavan J, Sethunath V, De Angelis C, et al
    Towards personalized treatment for early stage HER2-positive breast cancer.
    Nat Rev Clin Oncol. 2019 Dec 13. pii: 10.1038/s41571-019-0299.
    PubMed     Text format     Abstract available


    November 2019
  2. PONDE N, de Azambuja E
    PERSEPHONE - implications for clinical practice in 2019.
    Nat Rev Clin Oncol. 2019;16:663-664.
    PubMed     Text format    


    October 2019
  3. KILLOCK D
    Personalized MRD assays and therapy?
    Nat Rev Clin Oncol. 2019;16:593.
    PubMed     Text format    


    September 2019
  4. OH DY, Bang YJ
    HER2-targeted therapies - a role beyond breast cancer.
    Nat Rev Clin Oncol. 2019 Sep 23. pii: 10.1038/s41571-019-0268.
    PubMed     Text format     Abstract available


    August 2019
  5. SIDAWAY P
    Alpelisib effective in advanced-stage disease.
    Nat Rev Clin Oncol. 2019;16:466.
    PubMed     Text format    


  6. KILLOCK D
    Chemotherapy as a TONIC to invigorate PD-1 inhibition in TNBC.
    Nat Rev Clin Oncol. 2019;16:464.
    PubMed     Text format    


  7. ROMERO D
    HDAC inhibitors tested in phase III trial.
    Nat Rev Clin Oncol. 2019;16:465.
    PubMed     Text format    


    June 2019
  8. SIDAWAY P
    Fulvestrant enables better outcomes.
    Nat Rev Clin Oncol. 2019;16:337.
    PubMed     Text format    


  9. BRADLEY CA
    Brain metastases respond to neratinib plus capecitabine.
    Nat Rev Clin Oncol. 2019;16:336.
    PubMed     Text format    


    May 2019
  10. CUZICK J
    Predicting late recurrence in ER-positive breast cancer.
    Nat Rev Clin Oncol. 2019 May 15. pii: 10.1038/s41571-019-0228.
    PubMed     Text format    


  11. D'ABREO N, Adams S
    Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?
    Nat Rev Clin Oncol. 2019 May 3. pii: 10.1038/s41571-019-0216.
    PubMed     Text format    


  12. ROMERO D
    Healthier bones and less recurrence with denosumab.
    Nat Rev Clin Oncol. 2019;16:272.
    PubMed     Text format    


    April 2019
  13. SIDAWAY P
    Early PET response predicts complete response.
    Nat Rev Clin Oncol. 2019;16:208.
    PubMed     Text format    


  14. KILLOCK D
    CTCs 'piggyback' off neutrophils.
    Nat Rev Clin Oncol. 2019;16:208.
    PubMed     Text format    


    December 2018
  15. RICHMAN J, Dowsett M
    Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer.
    Nat Rev Clin Oncol. 2018 Dec 18. pii: 10.1038/s41571-018-0145.
    PubMed     Text format     Abstract available


    September 2018
  16. PONDE NF, Zardavas D, Piccart M
    Progress in adjuvant systemic therapy for breast cancer.
    Nat Rev Clin Oncol. 2018 Sep 11. pii: 10.1038/s41571-018-0089.
    PubMed     Text format     Abstract available


    June 2018
  17. SIDAWAY P
    Ribociclib effective in HR(+), HER2(-) breast cancer.
    Nat Rev Clin Oncol. 2018 Jun 21. pii: 10.1038/s41571-018-0059.
    PubMed     Text format    


    March 2018
  18. SIDAWAY P
    Breast cancer: Changes in clonal dynamics predict response to palbociclib.
    Nat Rev Clin Oncol. 2018 Mar 20. pii: nrclinonc.2018.
    PubMed     Text format    


  19. SIDAWAY P
    Breast cancer: Fibroblast subtypes alter the microenvironment.
    Nat Rev Clin Oncol. 2018 Mar 6. pii: nrclinonc.2018.
    PubMed     Text format    


    February 2018
  20. ROMERO D
    Breast cancer: Metronomic chemotherapy for elderly and/or frail patients.
    Nat Rev Clin Oncol. 2018 Feb 27. pii: nrclinonc.2018.
    PubMed     Text format    


  21. ROMERO D
    Breast cancer: Recurrent fusions in endocrine-resistant disease.
    Nat Rev Clin Oncol. 2018 Feb 6. pii: nrclinonc.2018.
    PubMed     Text format    


    January 2018
  22. VAZ-LUIS I, Partridge AH
    Exogenous reproductive hormone use in breast cancer survivors and previvors.
    Nat Rev Clin Oncol. 2018 Jan 23. pii: nrclinonc.2017.
    PubMed     Text format     Abstract available


    December 2017
  23. PEREZ-GARCIA J, Cortes J
    Breast cancer in 2017: Spurring science, marking progress, and influencing history.
    Nat Rev Clin Oncol. 2017 Dec 12. pii: nrclinonc.2017.
    PubMed     Text format    


    October 2017
  24. SIDAWAY P
    Breast Cancer: Abemaciclib effective in combination with aromatase inhibition.
    Nat Rev Clin Oncol. 2017 Oct 17. doi: 10.1038/nrclinonc.2017.
    PubMed     Text format    


  25. SIDAWAY P
    Breast cancer: LAG3 expression indicates favourable outcomes.
    Nat Rev Clin Oncol. 2017 Oct 10. doi: 10.1038/nrclinonc.2017.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: